Orphapacket:
  ORPHApacketId: '213767'
  creationDate: '2020-12-03 15:53:15'
  version: 1.3.6 / 4.1.7 [2020-04-17] (orientdb version)
  copyright: Orphanet (c) 2020
  ORPHAcode: '213767'
  Label: Squamous cell carcinoma of the cervix uteri
  PURL: http://www.orpha.net/ORDO/Orphanet_213767
  DisorderType:
    value: Disease
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
  Synonyms:
  - Synonym: Cervical squamous cell carcinoma
  Parents:
  - Parent:
    - ORPHAcode: '213761'
      Label: Rare cancer of cervix uteri
  Prevalences:
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Europe
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-5 / 10 000
      ValMoy: no data
      PrevalenceGeographic: Bulgaria
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-5 / 10 000
      ValMoy: no data
      PrevalenceGeographic: Estonia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-5 / 10 000
      ValMoy: no data
      PrevalenceGeographic: Lithuania
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Austria
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Belgium
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Croatia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Czech Republic
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Finland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Germany
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Iceland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Ireland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Italy
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Latvia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Malta
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Norway
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Poland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Portugal
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Slovakia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Slovenia
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Spain
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Switzerland
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: Netherlands
  - Prevalence:
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      PrevalenceType: Annual incidence
      PrevalenceQualification: Value and class
      PrevalenceClass: 1-9 / 100 000
      ValMoy: no data
      PrevalenceGeographic: United Kingdom
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: Adult
